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Epigenetic age acceleration (AA) has been associated with adverse environmental exposures 
and many chronic conditions. We estimated, in the NINFEA birth cohort, infant saliva 
epigenetic age, and investigated whether parental socioeconomic position (SEP) and 
pregnancy outcomes are associated with infant epigenetic AA. A total of 139 saliva samples 
collected at on average 10.8 (range 7-17) months were used to estimate Horvath’s DNA 
methylation age. Epigenetic AA was defined as the residual from a linear regression of 
epigenetic age on chronological age. Linear regression models were used to test the 
associations of parental SEP and pregnancy outcomes with saliva epigenetic AA. A moderate 
positive association was found between DNA methylation age and chronological age, with the 
median absolute difference of 6.8 months (standard deviation 3.9). The evidence of the 
association between the indicators of low SEP and epigenetic AA was weak; infants born to 
unemployed mothers or with low education had on average 1 month higher epigenetic age 
compared with infants of mothers with high education and employment (coefficient 0.78 
months, 95% confidence intervals (CI): -0.79, 2.34 for low/medium education; 0.96, 95% CI:-
1.81, 3.73 for unemployment). There was no evidence for association of gestational age, 
birthweight or caesarean section with infant epigenetic AA. Using the Horvath’s method, DNA 
methylation age can be fairly accurately predicted from saliva samples already in the first 
months of life. This study did not reveal clear associations between either pregnancy 
outcomes or parental socioeconomic characteristics and infant saliva epigenetic AA.  









A person’s chronological age is not always closely related to his/her biological age. Biological 
ageing occurs predominantly at cellular level as a result of accumulating cellular damages, 
caused by several molecular mechanisms, including mitochondrial dysfunction, oxidative 
stress, accumulation of aberrant proteins, somatic mutations, DNA damage and telomere 
shortening.1,2 These mechanisms are strongly regulated by the defence and repair systems, 
which maintain the cellular balance and functionality.3 Impairment of cellular maintenance 
pathways or increased accumulation of cellular damage due to extrinsic hazards compromise 
the cell function, leading to an increased velocity of biological ageing.1 
Chronological age is the strongest unmodifiable risk factor for mortality and major non-
communicable diseases, including cancer, cardiovascular and neurodegenerative diseases.4 
Evidence on environmental influences on the rate of accumulation of cellular damage, and 
therefore, biological ageing suggests that some of the adverse effects of aging could be, at least 
partially, modified.5 To date, numerous biomarkers to predict the biological age have been 
developed, starting from physical functions and anthropometric measurements to molecular 
and DNA-based biomarkers.6,7 Two of the most promising DNA-based age biomarkers are 
DNA methylation and telomere length, and several different methods to quantify the 
biological age using these biomarkers have been developed.7-10 
Horvath’s multi-tissue DNA methylation clock8 is the most widely used age biomarker in 
humans, with a strong correlation with chronological age (Pearson rho > 0.90 in studies with 
a wide age range). The epigenetic age acceleration (AA), i.e. the difference between epigenetic 
and chronological age, has been consistently associated with overall mortality and many 
chronic conditions, including cardiovascular diseases and cancer.11-14 Although the molecular 
mechanisms behind the epigenetic AA are largely unknown, epigenetic AA is one of the most 
popular measures of biological ageing. 
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Early life programming, induced by environmental factors at different stages of prenatal and 
early postnatal life, likely involves life-long alterations in the epigenetic programming and the 
regulation of gene transcription.15 In fact, emerging evidence supports the role of 
environmentally induced epigenetic variations in linking early life exposures to long-term 
outcomes. Epigenetic age and gestational age accelerations at birth and in childhood have 
been associated with both early life environment, including maternal characteristics, socio-
economic conditions and perinatal outcomes,16-20 and with numerous childhood health 
outcomes.20-24 
Socio-economic differences in health have been widely documented, and low socioeconomic 
position (SEP) is known to be one of the most important risk factors for ageing-related 
chronic diseases. Although parental SEP, early life and current socio-economic disadvantage 
have been reported to leave epigenetic signatures at birth,25 during childhood and in 
adulthood,25-27 findings on epigenetic AA are less consistent. For example, epigenetic AA has 
been associated with a low educational level in adulthood in a multi-cohort study,28 but not 
with low SEP in two UK cohorts of adult women17 and in two studies based on children from 
the UK ALSPAC birth cohort.16,20 
In addition to SEP, adverse pregnancy outcomes, such as low birthweight, preterm birth and 
delivery by caesarean section, are known to leave long-term health effects, and are found to 
be associated with specific epigenetic marks.29-31 The ALSPAC study, in their cord blood 
analysis,  reported epigenetic AA associated with caesarean delivery, but not with birthweight 
and gestational age.20 In the same study, peripheral blood epigenetic AA in childhood and 
adolescence was associated with birthweight, but with the opposite direction of the 
association. Also, gestational AA of the offspring at birth in a Finnish study of 814 mother-
newborn pairs was associated with several maternal risk factors and birth outcomes, 
including lower birth size and 1-min Apgar score.18 On the contrary, another study conducted 
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within the ALSPAC cohort (N=863) found greater cord blood gestational AA to be associated 
with larger birth size.16 
As few studies used biological samples other than blood to estimate epigenetic age in infancy, 
and given conflicting findings on the associations of SEP and pregnancy outcomes with early 
life epigenetic AA, we estimated, in the NINFEA (Nascita ed INFanzia: gli Effetti dell'Ambiente) 
birth cohort, saliva epigenetic age in children aged 7-17 months, and then, investigated 
whether parental socioeconomic status, pregnancy outcomes and caesarean section are 
associated with infant saliva epigenetic AA.  
Method 
Study population 
Data were taken from an epigenome-wide case-control study on early childhood wheezing, 
nested within the NINFEA birth cohort.32 The NINFEA study is an Italian web-based birth 
cohort that, during the period 2005-2016, recruited approximately 7500 pregnant women 
who had access to the Internet, enough knowledge of Italian to complete online 
questionnaires, and volunteered to participate (https://www.progettoninfea.it).33 Women 
completed the baseline questionnaire at enrolment, and children are currently followed up 
with six questionnaires completed by mothers 6 and 18 months after delivery, and when 
children turn 4, 7, 10 and 13 years of age. At the end of the 6‐month questionnaire, 
participating mothers were invited to collect their and their child's saliva samples, using the 
OrageneTM DNA self-collection kit (Infant Sponge Kit, CS-1, and OG-250, DNA Genotek, Inc., 
Ottawa, Ontario, Canada). Mothers who did not respond to this initial invitation were invited 
again at the end of the 18‐month and 4‐year questionnaire. Only children with saliva samples 
collected between 7 and 17 months of age were considered in this study. 
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The original case-control study was conducted within the subset of the NINFEA children who 
met the following criteria: i) singleton child, ii) saliva sample collected between 6 and 18 
months after birth, iii) residence in the Province of Turin, and iv) born to mother who did not 
have asthma during the index pregnancy. A total of 72 cases with at least one reported 
episode of wheezing between 6 and 18 months of age were matched to 72 controls by sex, age 
at sampling and seasonality/calendar year of sampling. Although information on children 
ethnic background was not available in the NINFEA cohort, almost the entire study population 
has both parents born in Italy, and only few study children have one of the parents born in 
other European countries. Therefore, the ethnic background of the children included in the 
study is, if not entirely, largely European. 
Saliva DNA methylation 
Saliva samples are stored in a biobank at -80°C. Genomic DNA was extracted from the selected 
144 saliva sponge samples by using the OrageneTM Purifier Solution (DNA Genotek, Inc., 
Ottawa, Ontario, Canada). Genomic DNA was bisulphite-converted using the EZ DNA 
Methylation-GoldTM Kit (Zymo Research, CA, USA) following the manufacturer’s protocol. The 
methylation status of over 485,000 probes was measured using the Infinium 
HumanMethylation450 BeadChip array (Illumina, Inc., San Diego, CA). The matched pairs 
were placed on the same chip to minimize confounding by batch. DNA methylation for each 
probe was expressed as beta-value (ratio of methylated probe intensity to overall intensity, 
representing 0 to 100% methylation at each probe). Pre-processing steps and quality control 
were described before.32,34 After quality control checks and probes filtering three samples 
with more than 1% of the CpGs with detection p-value>0.01 were excluded, resulting in a 
total of 141 samples and 421,782 probes included in this study. 
Saliva is known to have a heterogeneous cellular composition, mostly composed of buccal 
epithelial cells and leucocytes.35,36 In the absence of saliva reference methylomes, we used the 
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Houseman’s reference free method (RefFreeEWAS package in R)37 to estimate proportions of 
putative cell types based on their underlying methylomes. From the 10,000 most variable 
CpGs, we identified two latent variables as the optimal number of surrogates for cell-type 
mixture, which is in accordance with previously reported saliva cell heterogeneity profiles in 
older children.35,36 We then used the 421,782 CpGs to estimate the proportion of the two cell 
types per sample. 
Exposures 
We analysed the following socioeconomic factors: parental educational level (low—primary 
school or less / medium—secondary school, and high—university degree), parental 
unemployment (employed and unemployed) at the time of conception, family size (including 
the index child; 2 members, 3-4 members, and 5 and more members), maternal age at 
delivery and an indicator of the equivalised total disposable household income at birth (the 
highest three quintiles vs. the lowest two quintiles of the entire NINFEA cohort distribution). 
The equivalised total disposable household income indicator at birth has been developed 
within the European Horizon 2020 LifeCycle project and it uses external data from the pan-
European surveys “European Union Statistics on Income and Living Conditions” (EUSILC) and 
internal household and parental characteristics available within cohorts.38 For the NINFEA 
cohort, the income indicator has been constructed using the following parental and household 
baseline characteristics: cohabitation with partner, family size (number of children and adults 
in the household), dwelling type, number of rooms in the house, maternal age and country of 
birth, parental education and occupation and maternal job coded using the ISCO-88 
(International Standard Classification of Occupations) classification.38  
Pregnancy outcomes included birthweight (grams), gestational age (weeks), size for 
gestational age (small, appropriate and large for gestational age, based on the 10th and the 90th 
percentile of the World Health Organization birthweight for sex and gestational age charts),39 
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and mode of delivery (vaginal delivery vs. caesarean section). All variables were measured 
through questionnaires completed by mothers either during pregnancy (socioeconomic 
factors) or six months after delivery (pregnancy outcomes). 
Statistical analysis 
We estimated DNA methylation age for each infant saliva sample by applying the Horvath’s 
method to raw beta-values.8 Horvath used 8000 samples from 82 Illumina DNA methylation 
array data sets, across an extensive range of ages and tissue samples, to identity 353 DNA 
methylation sites predictive of chronological age.8 Two outliers in the NINFEA dataset were 
removed as their predicted epigenetic age estimates were 4 standard deviations above the 
sample mean, which resulted in a total of 139 samples for the subsequent analyses.  
As the Horvath’s age estimation method was developed using samples across wide age ranges, 
a new method for measuring DNA methylation age in children, named the Pediatric-Buccal-
Epigenetic (PedBE) clock, has been recently developed.40 This method was developed using 
buccal samples of individuals between 0 and 20 years of age, and it uses weighted DNA 
methylation values at 94 CpG sites to predict chronological age.40 Given the large 
predominance of buccal epithelial cells in saliva samples, especially in young children,35,36 we 
additionally estimated DNA methylation age using the PedBE clock, but decided to present 
these results only as a supplementary analysis (Supplementary Table S1, Supplementary 
Figure S1), as in the NINFEA dataset there was an extremely high correlation between the age 
estimated using the PedBE clock and the cell type proportions estimated using the 
Houseman’s reference free method (Supplementary Figure S2), Thus, studying the 




The Pearson’s correlation, the R2 and the median absolute difference (”median error”) 
between the predicted and chronological age were used to assess the performance of the 
Horvath’s age predictor. The individual epigenetic AA was defined as the residual from the 
linear regression of epigenetic age on chronological age. This measure of AA is independent of 
chronological age, with, relative to the chorological age, positive values indicating epigenetic 
age acceleration and negative values indicating epigenetic age deceleration. 
Using linear regression models, we tested the associations of parental SEP and pregnancy 
outcomes with the epigenetic AA (in months). For all analyses we fitted two models for each 
independent variable: i) Model 1 adjusted for child’s sex, technical batch (chip), the two 
estimated saliva cell type proportions, and child wheezing at age 6 to 18 months, as the 
indicator of being a case or a control in the original case-control study; and ii) Model 2 
additionally adjusted for maternal age and parity in the analyses of socio-economic factors, 
and for maternal age, parity, maternal education and pre-pregnancy body mass index (BMI) in 
the analyses of pregnancy outcomes. The Model 2 for maternal age at delivery was adjusted 
for maternal education, occupation, parity and pre-pregnancy BMI. Birthweight and 
gestational age were also mutually adjusted in Model 2. In the NINFEA cohort an equivalised 
total disposable household income indicator was predicted using, as one of the predictors, 
maternal age, so we excluded maternal age from the adjusted model of household income. 
Although maternal smoking during pregnancy is strongly associated with pregnancy 
outcomes and with offspring DNA methylation, the prevalence of smoking in our sample was 
rather low (N=3; 2.2%), so we did not adjust for maternal smoking in our analyses.  
Finally, to assess the relative contribution of individual CpG sites from the Horvath’s DNA 
methylation predictor to infant saliva epigenetic age estimates we ranked all 353 CpG sites 
according to their weight metric (%) calculated by multiplying each CpG interquartile range 
with the absolute value of the Horvath’s training coefficient for that CpG site. We compared 
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the top ranked CpG sites with those reported in another epigenetic age study based on 
newborn saliva samples.41 
All the analyses were performed using the computing environment R version 3.6.1 (R 
Development Core Team, 2019). 
Results 
The characteristics of the 139 children included in the analyses are shown in Table 1. The 
mothers were on average 34.5 years old at delivery, the two thirds were nulliparous and 
14.5% were obese or overweight before pregnancy. In the study sample 72.5% of the mothers 
were highly educated (University degree or higher), more than 90% of the mothers and 
almost all the fathers (97.8%) were employed, while the average predicted equivalised total 
disposable household income was 1768.6 euros per month. Among children, the mean 
gestational age at delivery was 39.5 weeks, the mean birthweight was 3241 grams, and 36.7% 
were delivered by caesarean section.  
The mean age at saliva sampling was 10.8 months (standard deviation (SD) 2.2; range 7-17), 
while the mean Horvath’s DNA methylation age was 17.5 months (SD 4.4; range 7.3-34.3) 
(Table 2). There was a positive association between chronological age and DNA methylation 
age (Pearson’s r=0.32, p-value = 0.0001, Figure 1). The correlation was moderate compared 
with the one reported in the original Horvath’s study (r >0.90 in most of the tissues and cell 
types)8 due to the much narrower chronological age range of our sample (7-17 months). 
Several studies with restricted sample age ranges reported analogous correlations between 
the estimated Horvath’s epigenetic age and chronological age.17,19,21-23 The median absolute 
difference (median error) between DNA methylation age and chronological age was 6.8 
months (mean 6.9; SD 3.9). 
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Using the weighting metric described in Methods, the twenty top ranked CpG sites, i.e. the 
strongest CpG predictors from the Horvath’s epigenetic clock in our study, contributed 
collectively to the 25.9% of the total weight metric. Among these, eleven CpGs overlapped 
with the twenty most influential CpG sites in the newborn saliva study by Phang et al,41 
adding to 14.9% of the total weight in our study and 21.0% in the study by Phang et al. The 
eleven overlapping CpG in studies on newborn/infant saliva map to the following genes: 
NHLRC1, CSNK1D, PPP1R14A, FZD9, FXN, RASSF4, BCMO1, SCGN, PAWR, RXRA and DPP8. 
The complete list of CpG sites, with their rankings and functional characteristics are shown in 
Supplementary Table S2. 
In the NINFEA saliva samples, the PedBE clock had weaker correlation with chronological age 
compared with Horvath’s epigenetic clock (Pearson’s r=0.24 for PedBE clock,  r=0.32 for 
Horvath’s epigenetic clock), and showed slightly higher saliva epigenetic age compared with 
Horvath’s epigenetic age method (Supplementary Table S1, Supplementary Figure S1).  
Parental socioeconomic characteristics, pregnancy outcomes and offspring saliva epigenetic AA 
The associations of parental socioeconomic characteristics and pregnancy outcomes with the 
offspring epigenetic AA are shown in Table 3 and Figure 2. Overall, there was a suggestion of 
an association between the indicators of low SEP and epigenetic AA, but the evidence for each 
indicator was weak, also due to large confidence intervals and low SEP-associated 
heterogeneity in the study sample. In particular, infants born to unemployed mothers or 
mothers with low or medium educational level had on average 1 month higher epigenetic age 
compared with infants of mothers with high education and employment (coefficient 0.78 
months, 95% confidence intervals (CI): -0.79, 2.34 for maternal low/medium educational 
level, and coefficient 0.96, 95%CI: -1.81, 3.73 for maternal unemployment). Similar estimates 
were also found for a low total household income (1st and 2nd quintile compared with the 
highest three quintiles 0.74, 95%CI: -0.95, 2.43) and large family size (>4 members compared 
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with 3-4 members 0.86; 95% CI: -2.02, 3.75). The estimate observed for paternal 
unemployment status (2.82 months; 95% CI: -2.23, 7.88) should be interpreted with caution 
as in our sample only three children had fathers who were unemployed (Table 1).  
In our study, there was no evidence for associations of gestational age, birthweight or delivery 
by caesarean section with infant saliva epigenetic AA estimated using Horvath’s epigenetic 
clock (Table 3, Figure 2).  
Similarly, we found no association of parental SEP or pregnancy outcomes with infant PedBE 
AA (data not shown). 
Discussion 
Using saliva samples from 139 infants of the NINFEA birth cohort study we examined 
epigenetic DNA methylation age, its correlation with chronological age and the associations of 
parental socioeconomic characteristics and pregnancy outcomes with epigenetic age 
acceleration/deceleration. We found a moderate association between epigenetic and 
chronological age in the first 1.5 years of life, and only an indication of an accelerated 
epigenetic aging in infants from lower socio-economic backgrounds. This study did not 
identify associations of gestational age, birthweight or delivery by caesarean section with the 
rate of early life epigenetic AA. 
The sample analysed in our study had a quite narrow age range (7-17 months, SD 2.2 
months), so the correlation between the estimated epigenetic and chronological age was 
moderate (Pearson’s r= 0.32), with the mean difference between epigenetic and chronological 
age of approximately six months. This is, however, expected and in line with other studies that 
analysed samples with low standard deviations in chronological age.8,17,19,21-23  
Most of the previous studies focused on the effects and causes of accelerated/decelerated 
epigenetic age in adult populations,42 and some studies reported that a difference between 
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DNA methylation age and chronological age may already occur at birth as a consequence of 
unfavourable prenatal environment.16,18,19 To our knowledge no studies looked at these 
changes in infancy. We showed that Horvath’s epigenetic clock predicts the chronological age 
in the first months of life, with a similar performance of studies based on saliva samples 
collected at later ages,22,43 and can be used to explore epigenetic AA in infancy.  
Previous findings on socio-economic status and epigenetic ageing are conflicting. An 
accelerated epigenetic ageing has been found in adults with early life or current socio-
economic disadvantage,27,28 but not all studies confirmed these associations,17,44 and no such 
epigenetic signatures were observed at birth or in childhood.16,20,45 We used several maternal, 
paternal and household SEP measures, as well as the predicted equivalised total disposable 
household income, which captures yet another dimension of SEP, namely the material 
property in the country-specific context. Our findings support previous findings of no strong 
association between parental SEP and the rate of offspring epigenetic ageing in the first years 
of life. Nevertheless, the direction of the association observed in our and other studies based 
on children may indicate that the changes observed in adults may initiate early in life and that 
these small effects may then accumulate as a result of life-long deprivation. It should be, 
however, acknowledged that despite the existing contrast between medium and high 
socioeconomic level in our sample, few children came from very low socioeconomic 
background, and therefore, the effect of severe early childhood deprivation might not have 
been captured in this study.  
The lack of association between gestational age and epigenetic AA is consistent with previous 
studies that assessed epigenetic AA either at birth from cord blood or later in childhood from 
peripheral blood samples, where there was nearly no association between Horvath’s 
epigenetic AA and gestational age.18,20 Horvath’s DNA methylation age was designed to 
estimate chronological age and its consistent weak association with gestational age could 
15 
 
reflect different postnatal age-specific changes unrelated to prenatal development. In fact, 
several tissue-specific gestational age predictors have been developed using DNA methylation 
from umbilical cord blood or blood spot samples,46,47 but only few CpG sites from these 
predictors overlap with the Horvath’s epigenetic age predictor. Despite these differences, 
gestational epigenetic age acceleration and deceleration have also been associated with some 
of the maternal characteristics and pregnancy and birth outcomes.16,18 In particular, the 
directions of the associations were mixed for birthweight, where a negative association with 
gestational AA was observed in a Finish study,18 while a positive association was reported in a 
UK study.16 Inconsistent findings on birthweight were also found using the Horvath’s method 
in another UK study based on the same cohort, where birthweight was not associated with 
epigenetic AA at birth, while the association was in the opposite direction in the analyses 
carried out in childhood compared to those conducted in adolescence.20 Similarly, we found 
no association between birthweight and saliva epigenetic age acceleration in infancy. 
In contrast with two previous studies,16,20 we did not find an accelerated epigenetic age in 
children born by caesarean section. It should be, however, noted that in both previous studies 
there was only a marginal positive association with caesarean delivery at birth, and that it 
disappeared later in childhood.  
Epigenetic AA can be seen as a proxy of adverse environmental exposures and a mechanism 
through which these exposures influence later disease risk, or as a consequence of adverse 
health outcomes. In fact, it has been associated both with prenatal and early postnatal 
environmental adversity and with later health outcomes, such as high BMI, asthma and 
mortality.11-14, 16-28 Despite mainly weak associations, epigenetic AA has been linked with 
multiple exposures and outcomes, which makes complicated the understanding of what is 
actually measured with DNA methylation clock. It could be seen as an overall epigenetic 
shifting in response to adverse events, not exclusive of any specific insult, but an intrinsic 
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response of an organism to unfavourable environment in general. If so, it is not unexpected 
that the associations reported so far with single adverse factors operating early in life are 
relatively small in magnitude and often inconsistent. However, even small‐magnitude effect 
sizes are important and could have functional relevance for later childhood and adulthood 
health. 
The lack of associations with parental SEP and pregnancy outcomes in our study may be due 
to several factors. First, most of the previous studies that found associations with these two 
groups of exposures estimated DNA methylation age using cord or peripheral blood samples. 
It is well-established that epigenetic mechanisms are cell type specific, so it might be well 
possible that pregnancy outcomes and SEP-related changes in epigenetic AA are not present 
in all tissues and cell types. Second, the potential epigenetics marks of prenatal exposures that 
are present at birth may be reversible (or, conversely, might further accumulate) postnatally. 
Due to the extensive growth and development in the first months of life, it is expected that the 
dynamic of epigenetic changes is particularly rapid in infancy, and thus the epigenetic marks 
of prenatal exposures might have already disappeared by the first year of life. Third, some of 
the characteristics analysed in our study, e.g. paternal unemployment, small family size and 
large for gestational age, had less than ten exposed children available for the analyses. The 
sample size was thus relatively small, and our results should be seen in the overall context of 
the available and the future literature rather than a single ultimate study with high statistical 
power.  
Conclusions 
We have provided evidence that, using the Horvath’s method, DNA methylation age can be 
fairly accurately predicted from saliva samples already in the first months of life. This is 
important as saliva represents one of the most easily accessible non-invasive biological 
samples for DNA methylation analyses in large population studies, especially at young ages. 
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Horvath’s epigenetic clock indicates only a suggestion of an accelerated epigenetic aging in 
infants from lower socio-economic backgrounds, and no evidence of association between 
epigenetic AA and pregnancy outcomes, including gestational age, birthweight and mode of 
delivery. 
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Table 1. Characteristics of the study population (N=139) 
 
Maternal characteristic N (%) or Mean 
(SD)   
Maternal age (years) 34.5 (4.0) 
Maternal parity  
Nulliparous 90 (66.7) 
≥1 previous pregnancies 45 (33.3) 
Missing 4 
Maternal pre-pregnancy BMI (kg/m2)  
Underweight 11 (8.0) 
Normal 107 (77.5) 
Overweight/Obese 17 (14.5) 
Missing 1 
Smoking during pregnancy  
No 136 (97.8) 
Yes 3 (2.2) 
  Parental socio-economic characteristics  
  Maternal educational level  
High 100 (72.5)  
Medium 36 (26.1) 
Low 2 (1.4) 
Missing 1 
Maternal employment status  
Employed 125 (90.6) 
Unemployed 13 (9.1) 
Missing 1 
Paternal educational level  
High 64 (46.4) 
Medium 54 (39.1) 
Low 20 (14.5) 
Missing 1 
Paternal unemployment status  
Employed 136 (97.8) 
Unemployed 3 (2.2) 
Predicted equivalised total disposable household income  
Euros 1768.6 (303.86) 
The NINFEA cohort quintiles  




3rd quintile 24 (18.9) 
4th quintile 32 (25.2) 
5th quintile 33 (26.0) 
Missing 12 
Family size (including the index child)  
2 members 4 (2.9) 
3 members 83 (59.7) 
4 members 41 (29.5) 







Pregnancy outcomes  
  Gestational age at delivery (weeks) 39.5 (1.5) 
Birthweight (grams) 3241 (450.1) 
Size for gestational age  
Small for gestational age 22 (15.8) 
Appropriate for gestational age 110 (79.2) 
Large for gestational age 7 (5.0) 
Mode of delivery  
Vaginal delivery 88 (63.3) 
Caesarean section 51 (36.7) 
  Matching variables  
  Case (child wheezing 6-18 months)  
No 68 (48.9) 
Yes 71 (51.1) 
Child sex  
Females 60 (43.2) 
Males 79 (56.8) 
Season of saliva sampling  
Spring or summer 75 (54.0) 
Autumn or winter 64 (46.0) 






























Table 2. Chronological age and predicted Horvath’s DNA methylation age in the NINFEA 
sample  
 




    Chronological age (months) 10.8 (2.2) 7.0, 17.0  
DNA methylation age (months) 17.5 (4.4) 7.3, 34.3  
Difference between epigenetic and chronological age    
Difference (months) 6.7 (4.3) -4.1, 19.2  
Absolute difference (months) 6.9 (3.9) 0.0, 19.2  
Median absolute difference (median error; months) 6.8 /  
Epigenetic age acceleration 
 
Coef. s.e. R2 
    
Epigenetic age ~ chronological age 
 
0.64 0.16 0.09 
Residuals (months) 
 
   
Mean; SD; Range 0.0  4.2 -10.5, 14.1 
Epigenetic age ~ chronological age + chip + cellular 
types 
0.75 0.17 0.20 
SD –Standard deviation 
Coef. – Linear regression coefficient  
s.e. – Standard error 





























Table 3. Associations of familial socio-economic status and pregnancy outcomes with 
saliva epigenetic AA in infants 
 
Familial socio-economic characteristics 
Epigenetic age acceleration (months)a 
Coef.b 
(95% CI) 
Adjusted coef.c  
(95% CI) 
Maternal age at delivery (per 5 years) 0.20 (-0.68, 1.08) 0.17 (-0.82; 1.17)d 
Maternal educational level   
High Reference Reference 
Medium / Low 0.60 (-0.92, 2.12) 0.78 (-0.79, 2.34) 
Maternal employment status   
Employed Reference Reference 
Unemployed 0.84 (-1.66, 3.35) 0.96 (-1.81, 3.73) 
Paternal educational level   
High Reference Reference 
Medium / Low 0.06 (-1.33, 1.45) 0.11 (-1.31, 1.53) 
Paternal employment status   
Employed Reference Reference 
Unemployed 2.76 (-2.22, 7.73) 2.82 (-2.23, 7.88) 
Predicted equivalised total disposable 
household income (quintiles of Euros) 
  
≥3rd quintile Reference Reference 
1st and 2nd quintile 0.81 (-0.85, 2.47) 0.74 (-0.95, 2.43)e 
Family size (including the index child)   
2 members -0.43 (-4.54, 3.67) -0.34 (-4.57, 3.89) 
3-4 members Reference Reference 




Adjusted coef.f  
(95% CI) 
Gestational age at delivery (weeks) 0.21 (-0.26, 0.69) 0.06 (-0.52, 0.64)g 
Birthweight (per 100 grams) 0.11 (-0.06, 0.27) 0.05 (-0.16, 0.26)g 
Size for gestational age   
Small 0.22 (-1.67, 2.10) 0.63 (-1.35, 2.60) 
Appropriate Reference Reference 
Large 1.77 (-1.75, 5.29) 0.80 (-3.09, 4.69) 
Mode of delivery   
Vaginal delivery Reference Reference 
Caesarean section 0.01 (-1.46, 1.49) 0.14 (-1.36, 1.65) 
Coef. – Regression coefficient; CI – Confidence Intervals 
a Unstandardized residual regressing DNA methylation age on chronological age 
b Adjusted for child sex, technical batch (chip), estimated saliva cell count types, and child wheezing. 
c Adjusted as b and additionally adjusted for maternal age and parity. 
d Adjusted as b and additionally adjusted for maternal education, occupation, parity, and pre-pregnancy 
body mass index (BMI) 
e Adjusted as b and additionally adjusted for maternal parity. 
f Adjusted as b and additionally adjusted for maternal age, parity, maternal education and maternal BMI. 





Figure 1 A scatterplot with a smoothed regression line and 95% confidence intervals 
showing associations between saliva DNA methylation age and chronological age in 












Figure 2 Coefficient estimates with 95% confidence intervals for the association of 
parental and familial socioeconomic characteristics and pregnancy outcomes with 
infant saliva epigenetic age acceleration (months). Reference groups: parental high 
education (University or higher), parental employment, high income (ranked to ≥3rd quintile), 
3-4 family members in the household, vaginal delivery. Model 1 adjustment (red): child’s sex, 
technical batch (chip), estimated saliva cell count types, and child wheezing as a selection 
factor; Model 2 adjustment (blue): as Model 1 and additional adjustment for maternal age and 
parity in analyses of socioeconomic characteristics, and for maternal age, parity, maternal 
education and maternal pre-pregnancy body mass index (BMI) in analyses of pregnancy 





















Determination of saliva epigenetic age in infancy,  
and its association with parental socioeconomic characteristics  












Supplementary Table S1……………………………………………………………..………………………………..2 
Supplementary Figure S1……………………………………………………………………………….……………3 
































Supplementary Table S1. Chronological age and the predicted pediatric buccal 
epigenetic age (PedBE clock) in the NINFEA sample (N=139; two samples with more 
than 4SD in PedBE clock were removed) 
 




    Chronological age (months) 10.8 (2.2) 7.0, 17.0  
Pediatric buccal epigenetic age (months) 18.3 (7.6) 8.3, 47.2  
Correlation between epigenetic and chronological age Pearson r p-value  
Pediatric buccal epigenetic age (months) 0.24 0.005  
Difference between epigenetic and chronological age Mean 
(SD) 
Range  
Pediatric buccal epigenetic age (months)    
Difference (months) 7.5 (7.4) -2.7, 33.6  
Absolute difference (months) 7.6 (7.2) 0.1, 33.6  
Regression epigenetic age ~ chronological age Coef. s.e. R2 
Pediatric buccal epigenetic age (months)    
Epigenetic age ~ chronological age 
 
0.82 0.29 0.05 
Epigenetic age ~ chronological age + chip
 + chip) 
1.00 0.32 0.04 
Epigenetic age ~ chronological age + chip + cell type 1 + cell
type 2 
 
0.58 0.11 0.89 
SD – Standard deviation 
Pearson r – Pearson correlation coefficient 
Coef. – Regression Coefficient 
s.e. – Standard error 

























Supplementary Figure S1. Scatterplot with smoothed regression line and 95% 
confidence intervals showing association of chronological age with Pediatric Buccal 
Epigenetic Clock estimated in infant saliva samples in the NINFEA birth cohort.  
 


























































Supplementary Figure S2. Scatterplot with smoothed regression line and 95% 
confidence intervals showing association of Pediatric Buccal Epigenetic Clock 
estimated in infant saliva samples with the two saliva cell type proportions estimated 
using Houseman’s reference-free method. 
 
 




































B. Houseman's cell type 2: Pearson's r=-0.93, p-value<2.2e-16      
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